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 Chronic tubulointerstitial nephropathy 
associated with urothelial carcinoma is 
described in three clinical entities in the 
renal literature: analgesic nephropathy, 
Chinese herbs nephropathy (CHN), and 
Balkan endemic nephropathy (BEN). 
 Bilateral calcifying renal papillary 
necrosis associated with interstitial 
fibrosis and tubular atrophy resulting 
in pronounced cortical retraction found 
in patients with long-term abuse of 
combined analgesics associated with 
addictive substances is characteristic of 
analgesic nephropathy ( Table 1 ). Using 
computed tomographic scanning without 
contrast medium as renal imaging tech-
nique allows a correct diagnosis for these 
patients. 1 
 Th e clinical expression and pathological 
lesions observed at different stages 
of CHN and BEN are strikingly similar 
except for the rate of their progression 
toward end-stage renal failure. Further-
more, a strikingly higher prevalence rate 
of women presenting with CHN is 
observed, whereas BEN is characterized 
by familial clustering ( Table 1 ). 
 In 1991, nephrologists in the area 
around Brussels, Belgium, noted an 
increasing number of relatively young 
women who presented with different 
degrees of renal failure. All had attended 
the same private  ‘ slimming ’ clinic and had 
ingested a mixture of several drugs and 
powdered extracts of Chinese herbs con-
taining  Aristolochia fangchi . 2 Th e exposure 
to the inadvertently added  Aristolochia 
plant containing aristolochic acid (AA) 
turned out to be the most likely cause of 
the renal injury and later development of 
urothelial-cell atypia and carcinoma. 
 Very soon aft er the publication of the 
index cases, patients presenting with a sim-
ilar clinicopathological entity were reported 
in several countries around the world. 
 A couple of years later, reports from 
Taiwan and mainland China confi rmed 
the high prevalence of chronic tubu-
lointerstitial renal disease in end-stage 
renal failure patients associated with the 
use of herbal medicines containing AA, 3 
partly explaining the very high incidence 
of end-stage renal disease in Taiwan, 
based on an excellent registration system 
covering the whole country. 
 Several experimental models in rabbits, 
rats, and mice were able to reproduce the 
nephrotoxic and carcinogenic eff ects of 
AA observed in humans. 4,5 Furthermore, 
the carcinogenic and mutagenic eff ects 
associated with the binding of metabolites 
of ingested AA to DNA have been 
extensively described  in vitro and  in vivo , 
resulting in the classifi cation of AA as a 
genotoxic carcinogen. 6 
 Cosyns  et al. 7 documented pathological 
evidence of urothelial malignancy and 
overexpression of p53, a tumor suppressor 
gene known to be mutated in several types 
of malignancies, in the removed kidneys 
of almost all CHN patients. A high preva-
lence of urothelial malignancy was con-
fi rmed a year later in the series of Nortier 
 et al. 8 Th e latter study also demonstrated 
that the risk of urothelial carcinoma was 
related to the cumulative intake of 
A. fangchi , and that all patients exposed to 
AA had AA-related DNA adducts in speci-
mens of renal tissue. 
 Already in 2001, there was a call to 
change the term  ‘ Chinese herbs nephro p-
athy ’ to  ‘ aristolochic acid nephropathy. ’ 9 
 Balkan endemic nephropathy (BEN) is 
a tubulointerstitial nephropathy and was 
described already some 50 years ago. Th e 
renal disease tends to occur in people 
older than 18 years and in members of the 
same household, typically living in farm-
ing villages located near tributaries of the 
Danube in the Balkan area and Romania. 
BEN has the same renal localization and 
association with upper urinary tract 
malignancy that are observed in patients 
with CHN. 10 
 Over the years an impressive number of 
potential etiological agents (factors) have 
been proposed, such as environmental 
factors, mycotoxins (in particular, ochra-
toxin A), heavy metals, viruses, and trace-
metal defi ciencies. However, none of these 
studies collected or delivered convincing 
toxico-epidemiological data. 
 The ochratoxin A (OTA) hypothesis 
was based on the fact that residents in 
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endemic regions are exposed to relatively 
high concentrations of OTA. 11 However, 
similar high exposure occurs throughout 
the world in farming communities that 
are largely free of chronic kidney disease 
and urothelial malignancy. Furthermore, 
chronic nephrotoxicity associated with 
dietary exposure to OTA has never been 
observed in humans. 12 
 Already in 1969 Ivi ć 13 proposed that 
ingestion of fl our contaminated with seeds 
from  Aristolochia clematitis may be the 
cause of BEN. He noted that seeds from 
these plants, which grew abundantly in 
local wheat fi elds, comingled with wheat 
grain during the harvesting process. He 
administered  Aristolochia seeds to animals 
that developed renal damage, and specu-
lated that human exposure to a toxic com-
ponent of  Aristolochia seeds could occur 
through ingestion of bread prepared with 
fl our derived from contaminated grain. 
However, his fi eld surveys and data failed 
to provide convincing evidence, and his 
astute observations were neglected for 
many decades. 
 Th e fi nding by Grollman and colleagues 
of AA-derived DNA adducts in renal cor-
tical and urothelial tumor tissue of patients 
with documented BEN, associated with 
the dominance of the A:T  T:A transver-
sions in the p53 tumor suppressor gene 
mutational spectrum, was a breakthrough 
in the identifi cation of AA as an etiologi-
cal agent of the upper tract malignancy 
observed in BEN. 14 Th e observed muta-
tional spectra in urothelial cancers among 
BEN patients resemble the mutational 
 ‘ signature ’ observed in cultured cells and 
rodents treated with AA. 15 
 Jelakovi ć  et al. 16 (this issue) now extend 
their previous observations, 14 presenting 
molecular epidemiological evidence relat-
ing urothelial-cell carcinoma of the upper 
urinary tract to dietary exposure to AA 
through the contamination of fl our pre-
pared from locally grown wheat grain in 
the endemic cohort. Aristolactam-DNA 
adducts were present in 70 % of the 
endemic cohort ( n  =  67) and in 94 % of 
subjects with A:T  T:A mutations in 
 TP53 . In contrast, neither aristolactam-
DNA adducts nor A:T  T:A mutations 
were detected in tumors of upper urinary 
tract carcinoma patients ( n  =  10) residing 
in non-endemic regions (regions not 
exposed to AA). 
 Jelakovi ć  et al. 16 propose a molecular 
epidemiological approach using deoxy-
adenosine-aristolactam adducts and  TP53 
mutational spectra as biomarkers of expo-
sure to and carcinogenic eff ects of AA in 
the evaluation of the disease in countries 
where  Aristolochia species have been used 
for medicinal purposes. 
 In summary, the etiology of CHN and 
BEN is exposure to  Aristolochia 
containing AA, a toxic component of all 
 Aristolochia species. Th e slower progres-
sion toward end-stage renal failure of 
patients with BEN has to do with lower 
doses of AA ingested during the con-
sumption of contaminated bread as com-
pared with the high dose of AA found in 
the herbal mixtures used by patients in the 
 ‘ slimming ’ clinic. Th e higher prevalence 
of women in the CHN cohorts can be 
attributed to the fact that young women 
are more likely to attend such clinics. 
 Recently, the National Toxicology 
Program reported that AA was carcino-
genic to humans. Th e report suggested 
that  ‘ sufficient ’ scientific evidence was 
available to conclude that exposure to AA 
causes urothelial cancer in humans 
through formation of DNA adducts 
(specifically, through binding of the 
reactive metabolite with adenine) and 
the resulting transversion mutations in 
oncogenes. 17 
 The exact mechanism, however, by 
which exposure to AA results in chronic 
renal damage remains uncertain. 
 In a recent study in mice, chronic 
administration of AA resulted in progres-
sive renal damage. AA was able to activate 
Smad signaling to mediate epithelial – mes-
enchymal transition and renal fi brosis via 
both transforming growth factor-  -
dependent and JNK / MAP kinase-depend-
ent mechanisms. Th e blockade of JNK and 
specifi c knock-down of Smad3, but not 
Smad2, were able to attenuate AA-stimu-
lated collagen matrix expression and epi-
thelial – mesenchymal transition. 18 
 Lebeau  et al. 19 showed the involvement 
of AA in the early proximal tubular dys-
function, such as low-molecular weight 
proteinuria, found in CHN. Th ey pro-
posed a causal relationship between DNA 
adduct formation, decreased megalin 
expression, and inhibition of receptor-
mediated endocytosis of low-molecular 
weight proteinuria. 
 In acute aristolochic acid nephropathy 
in mice, it was found that the AA adducts 
 Table 1  |  Diff erential diagnosis of some forms of chronic tubulointerstitial nephro-
pathy associated with urothelial carcinoma 
 Aristolochic acid nephropathy  
  Chinese herbs 
nephropathy 
 Balkan endemic 
nephropathy 
 Analgesic 
nephropathy 
 Etiology  Aristolochic acid  Analgesics   +  addictive 
substances 
 Course toward ESRF  6 months to 2 years   >  20 years   >  10 – 15 years 
 Kidney imaging  Shrunken, irregular 
contours, no 
calci fi cations 
 Shrunken, smooth 
surface, no 
calci fi cations 
 Shrunken, irregular 
contours, papillary 
necrosis, calcifi cations 
 Histology:    
  •  Cellular infi ltra-
tion 
  +    +    +   +  
  •  Fibrosis   +   +    +   +    +   +  
  •  Atrophy   +   +    +   +   +    +   +  
 Capillarosclerosis   +    +    +  
 Apoptosis   +   +    +   +   ? 
 Urothelial 
malignancies 
  +  upper tract   +  upper tract   +  a 
 Familial 
occurrence 
  −    +    −  
 a As long as phenacetin was part of the analgesic mixtures. ESRF, end-stage renal failure. 
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formed with DNA may lead to tubular 
epithelial cell apoptosis via p53-mediated 
signaling. 20 AA induced dephosphoryla-
tion of STAT3 and subsequent activation 
of p53 and tubular epithelial cell apopto-
sis. In contrast, overexpression of STAT3, 
p53 inhibition, or p53 knock-down with 
small interfering RNA attenuated AA-
induced tubular epithelial cell apoptosis. 
Th is supports the hypothesis that p53 pro-
motes renal injury in acute aristolochic 
acid nephropathy. Th ese results have to be 
interpreted with caution with regard to 
humans, in view of the slowly progressive 
character of the disease in patients. On the 
other hand, experiments conducted on 
tissue from patients with BEN indicate 
that p53 is also activated. 
 Some important conclusions can be 
inferred from the CHN and BEN stories. 
For more than 2500 years, the  Aristolochia 
(birthwort) species were among the most 
extensively described medicinal plants in 
the Chinese Ayuverdic, Egyptian, Greek 
( Figure 1 ), Coptic, and European litera-
ture because of their association with a 
multitude of pharmacological activities. 
Remarkably, it was not until the end of 
the eighteenth century that the fi rst obser-
vations of nephrotoxicity related to the 
use of  Aristolochia appeared in the litera-
ture. 21 Recently this magic plant turned 
out to contain a powerful nephrotoxic 
substance with an ability to induce uro-
thelial cancer. 
 Aristolochic acid nephropathy remains 
an underdiagnosed renal illness because of 
its lack of identifi cation in certain parts of 
the world. It remains an international pub-
lic-health problem that can be resolved only 
through implementation of measures to 
halt the risk of exposure to this toxic herb. 
 Th e renal community has to be made 
aware of the proposed concept that  ‘ CHN ’ 
and  ‘ BEN ’ are limitative misnomers. 
Excellent toxico-epidemiological research, 
the use of sophisticated biochemical 
methodologies, and exchange of informa-
tion in the context of the globalization of 
nephrology have proven that both clinical 
entities have a common etiology, that is, 
AA, justifying the use of  ‘ aristolochic acid 
nephropathy ’ to cover two clinical expres-
sions (CHN and BEN) of that disease. 
 Aristolochic acid nephropathy is an 
underdiagnosed and underestimated 
chronic renal disease associated with a very 
high risk of developing upper urinary tract 
urothelial carcinoma, worthwhile to trace in 
any patient with an unexplained unclassifi -
able progressive decline in renal function. 
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 Figure 1  |  Aristolochia plant from a copy by a Byzantine artist ( AD 512) of the treatise on 
pharmacology of antiquity,  De Materia Medica , written by the Greek military doctor 
Dioscorides Pedanius ( AD 40 – 90). The copy is currently conserved at the National Library of 
Austria, Medias Graecas 1, in Vienna. 
